We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$47.3B
AUM Growth
+$3.18B
Cap. Flow
+$116M
Cap. Flow %
0.24%
Top 10 Hldgs %
11.39%
Holding
2,836
New
148
Increased
1,004
Reduced
1,103
Closed
268

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$541M
2
QCOM icon
Qualcomm
QCOM
+$532M
3
CVX icon
Chevron
CVX
+$514M
4
COP icon
ConocoPhillips
COP
+$495M
5
COR icon
Cencora
COR
+$473M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$559M
2
GILD icon
Gilead Sciences
GILD
+$542M
3
LNG icon
Cheniere Energy
LNG
+$523M
4
LYB icon
LyondellBasell Industries
LYB
+$457M
5
VTRS icon
Viatris
VTRS
+$441M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.84%
2 Technology 17.7%
3 Energy 16.46%
4 Industrials 10.01%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEGA icon
1426
Pegasystems
PEGA
$4.7B
– –
-2,245,764
Closed -$68M
PRAX icon
1427
Praxis Precision Medicines
PRAX
$8.8B
– –
-235
Closed -$9.72K
PRTA icon
1428
Prothena Corp
PRTA
$455M
– –
-552
Closed -$11.4K
PTCT icon
1429
PTC Therapeutics
PTCT
$6.29B
– –
-571
Closed -$17.5K
QDEL icon
1430
QuidelOrtho
QDEL
$1.15B
– –
-7,551
Closed -$251K
QGEN icon
1431
Qiagen
QGEN
$8.47B
– –
-294
Closed -$12.4K
RAMP icon
1432
LiveRamp
RAMP
$2.3B
– –
-1,838
Closed -$56.9K
RARE icon
1433
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-718
Closed -$29.5K
RCKT icon
1434
Rocket Pharmaceuticals
RCKT
$355M
– –
-669
Closed -$14.4K
RCUS icon
1435
Arcus Biosciences
RCUS
$3.5B
– –
-545
Closed -$8.3K
REYN icon
1436
Reynolds Consumer Products
REYN
$5.37B
– –
-3,890,109
Closed -$109M
REZI icon
1437
Resideo Technologies
REZI
$5.34B
– –
-6,104,301
Closed -$119M
RGNX icon
1438
Regenxbio
RGNX
$622M
– –
-587
Closed -$6.87K
RHI icon
1439
Robert Half
RHI
$4.07B
– –
-1,628,919
Closed -$104M
RLAY icon
1440
Relay Therapeutics
RLAY
$4.06B
– –
-1,103
Closed -$7.19K
RNAM
1441
DELISTED
Avidity Biosciences
RNAM
– –
-622
Closed -$25.4K
RPRX icon
1442
Royalty Pharma
RPRX
$26B
– –
-36,353
Closed -$959K
RVMD icon
1443
Revolution Medicines
RVMD
$40B
– –
-1,056
Closed -$41K
RXRX icon
1444
Recursion Pharmaceuticals
RXRX
$1.6B
– –
-2,263
Closed -$17K
RYTM icon
1445
Rhythm Pharmaceuticals
RYTM
$7.28B
– –
-413
Closed -$17K
SAGE
1446
DELISTED
Sage Therapeutics
SAGE
– –
-701
Closed -$7.61K
SANA icon
1447
Sana Biotechnology
SANA
$913M
– –
-1,936
Closed -$10.6K
SCL icon
1448
Stepan Co
SCL
$1.31B
– –
-31
Closed -$2.6K
SLNO
1449
DELISTED
Soleno Therapeutics
SLNO
– –
-307
Closed -$12.5K
SMMT icon
1450
Summit Therapeutics
SMMT
$10.5B
– –
-944
Closed -$7.36K
56 57
58
59 60

Similar funds

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Pacer Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Pacer Advisors held 2,836 positions worth $47.3B, up 7.2% from $44.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pacer Advisors's Q3 2024 filing shows 148 new, 1,004 increased, 1,103 reduced and 268 closed positions. Its largest new stake was TechnipFMC: 7,077,502 shares worth $186M. The largest sale was 3M, an estimated $559M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Technology and Energy.

  • Pacer Advisors's largest Q3 2024 buy was TechnipFMC: 7,077,502 shares worth $186M.
  • Pacer Advisors added most to Airbnb in Q3 2024, an estimated $541M increase.
  • Pacer Advisors's biggest Q3 2024 reduction was 3M, cutting an estimated $559M.
  • Pacer Advisors fully exited Newell Brands in Q3 2024, selling an estimated $301M.
  • Pacer Advisors's ten largest holdings make up 11% of its $47.3B portfolio in Q3 2024.
  • Pacer Advisors opened 148 new positions and closed 268 in Q3 2024.
  • Pacer Advisors's portfolio value rose 7.2% quarter-over-quarter to $47.3B.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.